BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25982144)

  • 1. 5-Aminolevulinic acid-mediated sonodynamic therapy induces anti-tumor effects in malignant melanoma via p53-miR-34a-Sirt1 axis.
    Hu Z; Fan H; Lv G; Zhou Q; Yang B; Zheng J; Cao W
    J Dermatol Sci; 2015 Aug; 79(2):155-62. PubMed ID: 25982144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of antitumor activity by using 5-ALA-mediated sonodynamic therapy to induce apoptosis in malignant gliomas: significance of high-intensity focused ultrasound on 5-ALA-SDT in a mouse glioma model.
    Suehiro S; Ohnishi T; Yamashita D; Kohno S; Inoue A; Nishikawa M; Ohue S; Tanaka J; Kunieda T
    J Neurosurg; 2018 Dec; 129(6):1416-1428. PubMed ID: 29350596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Aminolevulinic acid-mediated sonodynamic therapy reverses macrophage and dendritic cell passivity in murine melanoma xenografts.
    Wang S; Hu Z; Wang X; Gu C; Gao Z; Cao W; Zheng J
    Ultrasound Med Biol; 2014 Sep; 40(9):2125-33. PubMed ID: 25023114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Aminolevulinic Acid-Mediated Sonodynamic Therapy Alleviates Atherosclerosis via Enhancing Efferocytosis and Facilitating a Shift in the Th1/Th2 Balance Toward Th2 Polarization.
    Yang Y; Liu Y; Chen X; Gong J; Huang Z; Wang W; Shi Y; Wang Y; Yao J; Shen Z; Tian Z; Jin H; Tian Y
    Cell Physiol Biochem; 2018; 47(1):83-96. PubMed ID: 29763901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-aminolevulinic acid sonodynamic therapy for cutaneous squamous cell carcinoma.
    Li C; Yan J; Wang P; Zhang H; Zeng Q; Zhang G; Wang X
    Photodiagnosis Photodyn Ther; 2023 Dec; 44():103801. PubMed ID: 37717674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Aminolevulinic Acid-Based Sonodynamic Therapy Induces the Apoptosis of Osteosarcoma in Mice.
    Li Y; Zhou Q; Hu Z; Yang B; Li Q; Wang J; Zheng J; Cao W
    PLoS One; 2015; 10(7):e0132074. PubMed ID: 26161801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthermotherapy enhances antitumor effect of 5-aminolevulinic acid-mediated sonodynamic therapy with activation of caspase-dependent apoptotic pathway in human glioma.
    Ju D; Yamaguchi F; Zhan G; Higuchi T; Asakura T; Morita A; Orimo H; Hu S
    Tumour Biol; 2016 Aug; 37(8):10415-26. PubMed ID: 26846106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P53/miR-34a/SIRT1 positive feedback loop regulates the termination of liver regeneration.
    Gong J; Cong M; Wu H; Wang M; Bai H; Wang J; Que K; Zheng K; Zhang W; Yang X; Gong J; Shi H; Miao M; Yuan F
    Aging (Albany NY); 2023 Mar; 15(6):1859-1877. PubMed ID: 36988541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-intensity ultrasound combined with 5-aminolevulinic acid administration in the treatment of human tongue squamous carcinoma.
    Lv Y; Fang M; Zheng J; Yang B; Li H; Xiuzigao Z; Song W; Chen Y; Cao W
    Cell Physiol Biochem; 2012; 30(2):321-33. PubMed ID: 22739213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
    Luan S; Sun L; Huang F
    Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of p53/miR-34a/SIRT1 axis ameliorates podocyte injury in diabetic nephropathy.
    Liang Y; Liu H; Zhu J; Song N; Lu Z; Fang Y; Teng J; Dai Y; Ding X
    Biochem Biophys Res Commun; 2021 Jun; 559():48-55. PubMed ID: 33932899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
    Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
    J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the miR-34a/SIRT1/p53 Signaling Pathway Contributes to the Progress of Liver Fibrosis via Inducing Apoptosis in Hepatocytes but Not in HSCs.
    Tian XF; Ji FJ; Zang HL; Cao H
    PLoS One; 2016; 11(7):e0158657. PubMed ID: 27387128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sonodynamic therapy improves anti‑tumor immune effect by increasing the infiltration of CD8+ T cells and altering tumor blood vessels in murine B16F10 melanoma xenograft.
    Peng Y; Jia L; Wang S; Cao W; Zheng J
    Oncol Rep; 2018 Oct; 40(4):2163-2170. PubMed ID: 30106435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sinoporphyrin sodium based sonodynamic therapy induces anti-tumor effects in hepatocellular carcinoma and activates p53/caspase 3 axis.
    Li E; Sun Y; Lv G; Li Y; Zhang Z; Hu Z; Cao W
    Int J Biochem Cell Biol; 2019 Aug; 113():104-114. PubMed ID: 30660690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-34a repression of SIRT1 regulates apoptosis.
    Yamakuchi M; Ferlito M; Lowenstein CJ
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13421-6. PubMed ID: 18755897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbon monoxide protects against hepatic ischemia/reperfusion injury by modulating the miR-34a/SIRT1 pathway.
    Kim HJ; Joe Y; Yu JK; Chen Y; Jeong SO; Mani N; Cho GJ; Pae HO; Ryter SW; Chung HT
    Biochim Biophys Acta; 2015 Jul; 1852(7):1550-9. PubMed ID: 25916635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expression.
    Murray MY; Rushworth SA; Zaitseva L; Bowles KM; Macewan DJ
    Cell Cycle; 2013 Jul; 12(13):2144-53. PubMed ID: 23759586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of miR-34a/SIRT1/p53 signaling contributes to cochlear hair cell apoptosis: implications for age-related hearing loss.
    Xiong H; Pang J; Yang H; Dai M; Liu Y; Ou Y; Huang Q; Chen S; Zhang Z; Xu Y; Lai L; Zheng Y
    Neurobiol Aging; 2015 Apr; 36(4):1692-1701. PubMed ID: 25638533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytes.
    Herbert KJ; Cook AL; Snow ET
    Toxicol Appl Pharmacol; 2014 Jun; 277(3):288-97. PubMed ID: 24726431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.